|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Nabriva Therapeutics plc (NBRV)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-08-30 Purchase |
2019-09-03 4:04 pm |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
10,177 | $2.031 | $20,668 | 208,750 (Direct) |
View |
| 2019-08-27 Purchase |
2019-08-28 4:01 pm |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
50,000 | $1.79 | $89,500 | 117,489 (Direct Indirect) |
View |
| 2019-08-22 Purchase |
2019-08-26 9:49 pm |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
4,800 | $2.037 | $9,780 | 15,972 (Direct) |
View |
| 2019-08-21 Sale(A) |
2019-08-26 9:36 pm |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
10,177 | $2.07 | $21,066 | 125,724 (Direct) |
View |
| 2019-08-21 Sale(A) |
2019-08-26 9:35 pm |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
8,206 | $2.08 | $17,068 | 52,386 (Direct) |
View |
| 2019-08-21 Sale(A) |
2019-08-26 9:35 pm |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
3,797 | $2.08 | $7,898 | 23,239 (Direct) |
View |
| 2019-08-21 Sale(A) |
2019-08-26 9:35 pm |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
3,390 | $2.08 | $7,051 | 19,214 (Direct) |
View |
| 2019-08-21 Sale(A) |
2019-08-26 9:34 pm |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
3,797 | $2.08 | $7,898 | 11,172 (Direct) |
View |
| 2018-12-24 Purchase |
2018-12-27 4:05 pm |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
53,000 | $1.31 | $69,430 | 53,000 (Direct) |
View |
| 2018-07-31 Purchase |
2018-08-02 5:52 pm |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
14,500 | $2.75 | $39,875 | 47,640 (Direct) |
View |
| 2018-07-31 Purchase |
2018-08-02 5:51 pm |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
36,000 | $2.75 | $99,000 | 36,000 (Direct) |
View |
| 2018-06-23 Purchase |
2018-06-26 09:09 am |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. Chief Scientific Officer |
10,000 | $3.82 | $38,200 | 22,740 (Direct) |
View |
| 2018-06-22 Purchase |
2018-06-25 09:47 am |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
5,500 | $3.73 | $20,515 | 5,500 (Direct) |
View |
| 2018-06-22 Purchase |
2018-06-25 09:47 am |
Nabriva Therapeutics plc | NBRV | Broom Colin MD CEO |
5,000 | $3.72 | $18,600 | 102,151 (Indirect Direct) |
View |
| 2018-05-23 Purchase |
2018-05-29 1:48 pm |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
2,160 | $4.6 | $9,936 | 3,719 (Direct) |
View |
| 2018-05-23 Purchase |
2018-05-23 8:38 pm |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
2,000 | $4.57 | $9,140 | 6,200 (Direct) |
View |
| 2018-05-23 Purchase |
2018-05-23 8:37 pm |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
8,000 | $4.59 | $36,720 | 8,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-08-19 Exercise |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
11,250 | $0 | 22,604 (Direct) |
View |
| 2019-08-19 Tax Withholding |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
3,390 | $2.08 | 22,604 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
11,250 | $0 | 22,604 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
33,750 | $0 | 135,901 (Direct) |
View |
| 2019-08-19 Tax Withholding |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
10,177 | $2.07 | 135,901 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
33,750 | $0 | 135,901 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
11,250 | $0 | 27,036 (Direct) |
View |
| 2019-08-19 Tax Withholding |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
3,797 | $2.08 | 27,036 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:22 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
11,250 | $0 | 27,036 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
11,250 | $0 | 14,969 (Direct) |
View |
| 2019-08-19 Tax Withholding |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
3,797 | $2.08 | 14,969 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
11,250 | $0 | 14,969 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
11,250 | $0 | 55,776 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
16,000 | $0 | 55,776 (Direct) |
View |
| 2019-08-19 Tax Withholding |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
3,390 | $2.08 | 55,776 (Direct) |
View |
| 2019-08-19 Tax Withholding |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
4,816 | $2.08 | 55,776 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
11,250 | $0 | 55,776 (Direct) |
View |
| 2019-08-19 Exercise |
2019-08-21 9:21 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
16,000 | $0 | 55,776 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:20 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:20 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | CORRIGAN MARK Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:19 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:17 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | Talbot George Harrison Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:16 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:16 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | Broom Colin MD Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-31 Option Award |
2019-08-01 4:15 pm |
N/A 2029-07-31 |
Nabriva Therapeutics plc | NBRV | Webster Stephen W Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2019-07-25 Option Award |
2019-07-25 5:16 pm |
N/A N/A |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
6,748 | $0 | 67,489 (Indirect) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
278,400 | $0 | 278,400 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
105,750 | $0 | 278,400 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
138,200 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:07 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Sender Gary CFO |
52,500 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
138,200 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Lavino Francesco Maria Chief Commercial Officer |
52,500 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
138,200 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Crotty Robert Gen Counsel & Corp Secretary |
52,500 | $0 | 138,200 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
235,000 | $0 | 235,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:06 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Schranz Jennifer Chief Medical Officer |
52,500 | $0 | 235,000 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:05 pm |
N/A 2029-01-31 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
429,800 | $0 | 429,800 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 4:05 pm |
N/A 2023-01-31 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
163,250 | $0 | 429,800 (Direct) |
View |
| 2018-08-02 Option Award |
2018-08-03 7:31 pm |
N/A 2028-08-02 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
7,500 | $0 | 32,000 (Direct) |
View |
| 2018-08-02 Option Award |
2018-08-03 7:31 pm |
N/A 2020-01-31 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
32,000 | $0 | 32,000 (Direct) |
View |
| 2018-08-01 Option Award |
2018-08-02 5:53 pm |
N/A 2028-08-01 |
Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2018-07-31 Option Award |
2018-08-02 5:51 pm |
N/A 2028-08-01 |
Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director |
15,000 | $0 | 36,000 (Direct) |
View |
| 2018-07-25 Option Award |
2018-07-27 5:30 pm |
N/A 2028-07-25 |
Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO |
77,500 | $0 | 77,500 (Direct) |
View |
| 2018-07-25 Option Award |
2018-07-27 5:29 pm |
N/A 2028-07-25 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
850,000 | $0 | 850,000 (Direct) |
View |
| 2018-07-25 Option Award |
2018-07-27 5:29 pm |
N/A 2020-01-31 |
Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO |
150,000 | $0 | 850,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Wed, 16 Oct 2019 22:12:41 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |